Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Breast Neoplasms 8Lymphoma, Follicular 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Breast Cancer Female 1

Interventions

Cyclophosphamide 7Therapeutics 5Flow Cytometry 5Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Filgrastim 4Polymerase Chain Reaction 3Immunoenzyme Techniques 3sargramostim 2liposomal amphotericin B 2aldesleukin 2Stem Cell Factor 2Rituximab 2Psychiatric Rehabilitation 2Ondansetron 2Mycophenolic Acid 2Methylprednisolone 2Melphalan 2Itraconazole 2Immunologic Techniques 2Etoposide 2Dexamethasone 2Caspofungin 2Capecitabine 2Calcium Dobesilate 2Aprepitant 2Antilymphocyte Serum 2Amplified Fragment Length Polymorphism Analysis 2Amifostine 2Alemtuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × Radiofrequency Ablation × Breast × Clear all
NCT07206121 2026-02-11

Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery

Innoblative Designs, Inc.

Phase NA Recruiting
10 enrolled
BreastLymphoid

Breast Neoplasms, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡